Current Strategies for Identifying and Validating Targets for New Treatment-Shortening Drugs for TB
Journal:
Current Molecular Medicine
Volume:
7
Page:
297-307
Author(s):
Kerstin J. Williams and Ken Duncan
Molecular Tools for Typing and Branding the Tubercle Bacillus
Journal:
Current Molecular Medicine
Volume:
7
Page:
309-317
Author(s):
Marcel A. Behr and Serge Mostowy
Correlates of Immune Protection from Tuberculosis
Journal:
Current Molecular Medicine
Volume:
7
Page:
319-325
Author(s):
Helen A. Fletcher
Th2 Cytokines in Susceptibility to Tuberculosis
Journal:
Current Molecular Medicine
Volume:
7
Page:
327-337
Author(s):
Graham A. W. Rook
New Agents for the Treatment of Tuberculosis on Clinical Study Phases II/III
Journal:
Current Respiratory Medicine Reviews
Volume:
3
Page:
101-106
Author(s):
Marcus B. Conde and Margarita Elsa Villarino
Nitric Oxide: Friendly Rivalry in Tuberculosis
Journal:
Current Signal Transduction Therapy
Volume:
2
Page:
121-128
Author(s):
Sangita Mukhopadhyay, Shiny Nair and Seyed E. Hasnain
Antimicrobial Evaluation of Some Arylsulfanylpyrazinecarboxylic Acid Derivatives
Journal:
Medicinal Chemistry
Volume:
3
Page:
277-280
Author(s):
Josef Jampilek, Martin Dolezal and Vladimir Buchta
In Search of New Cures for Tuberculosis
Journal:
Medicinal Chemistry
Volume:
3
Page:
301-316
Author(s):
Marina Protopopova, Elena Bogatcheva, Boris Nikonenko, Sam Hundert, Leo Einck and Carol A. Nacy
Carbonic Anhydrases as Drug Targets - An Overview
Journal:
Current Topics in Medicinal Chemistry
Volume:
7
Page:
825-833
Author(s):
Claudiu T. Supuran
Lipid-Specific Immune Responses Against Tuberculosis: From Basic Science to Medical Applications
Journal:
Current Immunology Reviews (Discontinued)
Volume:
3
Page:
145-150
Author(s):
Isamu Matsunaga and Masahiko Sugita